Estimation of utility weights for human papilloma virus-related health states according to disease severity

Table 3 Utility weights derived from the VAS and SG

Scenario		1. HPV-positive	2. CIN grade I	3. CIN grade II/III	4. Cervical cancer (simple or radical hysterectomy)	5. Cervical cancer (radical hysterectomy + radiotherapy + (chemotherapy))	6. Cervical cancer (chemoradiation)	7. Cervical cancer (chemotherapy)	8. Condyloma
VAS	N	415	475	431	439	415	412	418	427
	Mean	0.73	0.61	0.60	0.59	0.50	0.42	0.18	0.66
	SD	0.15	0.17	0.18	0.19	0.18	0.15	0.15	0.18
	Median	0.78	0.64	0.63	0.61	0.53	0.43	0.14	0.70
	1st quartile	0.67	0.50	0.49	0.47	0.37	0.33	0.07	0.55
	3rd quartile	0.84	0.72	0.73	0.72	0.63	0.50	0.25	0.80
SG	N	535	538	535	542	542	538	544	516
	Mean	0.83	0.774	0.773	0.71	0.65	0.60	0.43	0.78
	SD	0.26	0.27	0.28	0.32	0.31	0.28	0.32	0.29
	Median	0.95	0.90	0.90	0.85	0.78	0.70	0.40	0.90
	1st quartile	0.80	0.70	0.70	0.45	0.40	0.35	0.10	0.70
	3rd quartile	1.00	0.95	0.95	0.95	0.90	0.80	0.70	1.00

HPV human papilloma virus, CIN cervical intraepithelial neoplasia, VAS visual analogue scale, SD standard deviation, SG standard gamble